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miRo ` is a web-based knowledge base that provides users with miRNA–phenotype associations in humans. It integrates data
from various online sources, such as databases of miRNAs, ontologies, diseases and targets, into a unified database
equipped with an intuitive and flexible query interface and data mining facilities. The main goal of miRo ` is the establish-
ment of a knowledge base which allows non-trivial analysis through sophisticated mining techniques and the introduction
of a new layer of associations between genes and phenotypes inferred based on miRNAs annotations. Furthermore, a
specificity function applied to validated data highlights the most significant associations. The miRo ` web site is available at:
http://ferrolab.dmi.unict.it/miro.
Database URL: http://ferrolab.dmi.unict.it/miro
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Introduction
Post Transcriptional Gene Silencing (PTGS) is a highly con-
served mechanism of gene expression regulation and
microRNAs (miRNAs) are its main actors. These little RNA
molecules are able to bind to specific sites located in the
30 untranslated regions (UTRs) of target transcripts, inhibit-
ing their translation or promoting their degradation (1,2).
Although much effort has demonstrated their crucial role
in several physiological and pathological processes, their
mechanisms of action still remain unclear.
The knockout of a single miRNA may dramatically affect
the phenotype of an organism (3). Evidence suggests that
a miRNA may target more than one gene, often in several
sites, and that one gene may be targeted by many miRNAs
acting cooperatively. Many computational predictions
of miRNA targets are available on the web, but a precise
association between miRNAs and phenotypes has been
demonstrated only for few cases. Much more is known
about genes: for example, the Gene Ontology (GO; http://
www.geneontology.org/) database (4) provides annota-
tions for processes and functions in which they are
involved. Moreover, there is a vast literature concerning
genetic roles in pathologies. Nonetheless, miRNAs may
be annotated with information about their validated or
predicted targets. For example it is known that the anti-
apoptotic gene BCL-2 is involved in ‘B-Cell Chronic
Lymphocytic Leukemia’ (CLL) and it has been shown that
low expression of miR-15a and miR-16 is related to over-
expression of BCL-2 in a number of CLL patients (5).
Consequently, miR-15a and miR-16 may be functionally
associated with ‘apoptosis’ and ‘CLL’.
A common approach in the study of diseases or biolog-
ical processes involving miRNAs, requires the extraction of
data from several independent sources, such as miRNA/
target prediction databases, gene functional annotations,
expression profiles and biomedical literature.
Thus, there is a need for a system that integrates data
from heterogeneous sources in order to build extensible
and updatable knowledge bases. This system should be
equipped with mining algorithms capable of inferring
new knowledge.
The first system for functional annotation of miRNAs
is miRGator (6), a database which integrates data from
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makes it available through a set of standard queries.
Although miRGator represents a first attempt at the inte-
gration of such data, it has several limitations. It does not
provide information about the diseases, nor does it imple-
ment customizable queries or data mining facilities.
Here we present miRo `, a new system which provides
users with miRNA–phenotype associations in humans.
miRo ` is a web-based environment that allows users to
perform simple searches and sophisticated data mining
queries. The main goal of miRo ` is to provide users with
powerful query tools for finding non-trivial associations
among heterogeneous data and thereby to allow the iden-
tification of relationships among genes, processes, func-
tions and diseases at the miRNA level. Finally, the data
mining module includes a specificity function allowing
selection of the most significant associations among vali-
dated data.
Description of the system
Data Integration
The miRo ` web site integrates data from different sources,
as shown in Figure 1. miRNAs are annotated with informa-
tion about their precursor and mature sequences coming
from miRBase (http://microrna.sanger.ac.uk/sequences/) (7),
and with expression profiles obtained from the Mammalian
microRNA Atlas (8). The miRNA Atlas contains expression
patterns of pre-miRNAs and mature miRNAs in several
kinds of tissues, both normal and malignant. miRNAs
are also associated to GO terms and diseases through
their targets: each miRNA inherits all the annotations of
its target genes. Experimentally supported miRNA/target
pairs come from miRecords (http://mirecords.umn.edu/
miRecords/) (9). The predicted targets are taken from
the web sites of TargetScan (http://www.targetscan.org/)
(10), PicTar (http://pictar.mdc-berlin.de/) (11) and miRanda
(http://www.microrna.org/) (12). The target genes records
are enriched with general information such as genomic
context and transcript-related data coming from the NCBI
Gene and Nucleotide Databases (http://www.ncbi.nlm.nih
.gov/). The ontological terms with which the target genes
are annotated (processes and functions) are obtained
from the GO Database. Finally, the gene–disease relations
come from the Genetic Association Database (GAD; http://
geneticassociationdb.nih.gov/) (13), which is a database
of human genetic association studies of complex diseases
and disorders.
All the data are collected and maintained up-to-date in
a MySQL database. In particular, the most relevant data
about the miRNAs and the target genes, such as the geno-
mic contexts and the sequences, are stored in the database
for an immediate availability, while links to the original
sources are provided for more detailed information. The
data are retrieved from the source websites as flat files
except for GO, which is provided as a mySQL db dump
and the miRNA Atlas, which is given as a collection of
Excel spreadsheets. Initially, miRNA information from the
miRBase files is stored. Then, all the target prediction data
are screened and stored together with information on the
Figure 1. The miRo ` knowledge base schema. (a) miRNAs are annotated with their features coming from miRBase and their
expression profiles coming from the miRNA Atlas. They are linked to processes, functions and diseases through their predicted
(by TargetScan, PicTar and miRanda) or validated target genes (miRecords). (b) In this case, miR-16 has two validated
targets, BCL2 and CCND1, among others. These genes are annotated with GO terms and diseases, thus miR-16 inherits these
annotations.
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aliases are also stored, in order to facilitate the subsequent
integrations. In the prediction files, the genes are identified
by their NCBI IDs, while the miRNAs are identified either
by their accessions (miRanda) or their IDs (TargetScan
and PicTar). The genes are then annotated with their GO
terms, coming from the GO Database, and their associated
diseases, retrieved from GAD. Since in both cases the genes
are identified by their names, the gene aliases are often
used in this step, in order to correctly identify all of them.
Finally, miRNA expression profiles are integrated. For each
miRNA, identified by its ID, all the expressing tissues,
together with the expression values, are stored. The per-
centage distribution of miRNA clones in the tissues is also
computed and then stored for fast retrieval.
Inconsistencies in data integration are prevented by a
semi-automatic process: the system automatically detects
and reports in a logfile any mismatches, which are then
resolved manually. For example, all the miRNA names
in the prediction files (PicTar and TargetScan) which can
not be found in the miRBase data (e.g. their IDs have
been changed), are reported in the logfile. The automatic
procedure also retrieves all the similar names in the
database. These are then manually screened, sometimes
using also sequence information, in order to find the cor-
rect ones.
The system also automatically checks for new releases
of the source databases every three months and performs
an update if needed.
The miRo ` web interface
The miRo ` web interface allows the user to perform four
different types of queries. A simple search is used to get
information about a single object, which can be a miRNA,
a gene, a process, a function, a disease or a tissue. For
example, it is possible to specify a miRNA or to choose
one from the complete miRNA catalog to get the list of
all the diseases and GO Terms (Processes and functions)
which can be associated to that miRNA through its targets.
The results are ordered by the number of tools which pre-
dict the corresponding miRNA–target pairs and the exper-
imentally supported associations are always given first.
Using the ‘AND’ constraint enables users to select only
the terms associated to the targets predicted by all the
selected tools. This may help to identify the most strongly
supported associations, and reduce the falsely predicted
associations.
Similarly, the user can search for all the miRNAs asso-
ciated to a certain gene, disease, process or function and
obtain a list of all the miRNAs expressed in a certain tissue
with their expression levels.
A customized search also allows users to extend the
knowledge base by a personal set of miRNA–target pairs.
These pairs will be temporarily stored and used in all the
session queries. This feature may be helpful in testing new
miRNA–target data.
The advanced search form can be used to perform more
sophisticated queries. The user chooses a ‘subject’ among
miRNA, gene, disease, process and function, then specifies
a list of constraints that the subject must satisfy.
For example, it is to possible to ask miRo ` to show all
the miRNAs (the subject is ‘miRNA’) which are associated
to ‘heart failure’, ‘RNA binding’ and ‘apoptosis’, but not to
‘congenital heart diseases’. The user may also choose the
sources of the miRNA–target pairs. This allows to tighten
or relax the query conditions, in order to get a smaller or
a larger output, respectively. The system will show the list
of all the miRNAs which satisfy these constraints, with
details about the involved targets (Figure 2). This query
tool links objects through miRNA-based associations. For
example, a disease d and a process p which are not linked
through any common gene might be associated through
a miRNA which regulates a gene gd, involved in d, and
a gene gp, involved in p. This introduces a new layer of
associations between genes and processes inferred based
on miRNAs annotations. These associations are given in
the Advanced Search results pages, when the subject of
the query is a GO term or a disease.
Data mining
Maximal frequent item sets of miRNAs
Since miRNAs are associated to GO terms and diseases, they
can be clustered according to their common terms, i.e.
miRNAs which are associated to the same set of terms are
grouped together. miRo ` is equipped with a data mining
module, based on a maximal frequent item set computa-
tion (14,15), which allows users to query the database
and extract non-trivial subsets of miRNAs sharing some
features. The analysis is performed using different support
thresholds: a high threshold allows to obtain a small
number of miRNA subsets associated to a great number
of terms, while a low threshold gives more subsets
associated to fewer terms. All the subsets have been pre-
computed off-line on the dataset of the validated miRNA–
target pairs.
In the miRo ` interface, the user may choose up to n
miRNAs together with an association criteria (i.e. process
or disease). The system will find all the subsets of the
selected miRNAs and the processes or diseases which they
are most closely associated to. This may suggest that a set
of miRNAs acting cooperatively carry out certain biological
functions, as will be shown in the next section. Moreover,
miRNA–term associations are scored in order to highlight
the most significant ones, as discussed in the next
subsection.
.............................................................................................................................................................................................................................................................................................
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Each miRNA–process or miRNA–disease pair, in each subset,
is scored according to a specificity scoring function. This
evaluates the relationships between the miRNAs and their
annotation terms (processes and diseases). The specificity of
a miRNA mk for a process pj is defined as follows:
Smk,pj ¼
Gmk,pj
     
     
Gmk
         
P
gi2Gmk,pj
Sgi
Gmk,pj
     
     
¼
P
gi2Gmk,pj
Sgi
Gmk
       
where Gmk,pj is the set of the target genes of miRNA mk
involved in the process pj, and Gmk is the set of all the tar-
get genes of mk. The specificity of a gene Sgi is inversely
proportional to the number of processes in which the gene
is involved:
Sgi ¼
1
Pgi
       
where Pgiis the set of the processes in which the gene gi
is involved.
Intuitively, a gene associated with fewer processes is
more focused on the ones remaining. The specificity of
a miRNA for a process relies on the number of targets
and their specificity to the process.
This function has been applied to the set of validated
miRNA–target interactions. The subsets of frequently asso-
ciated miRNAs are visualized by tables showing the miRNAs
and the processes/diseases to which they are all associated,
with their specificity scores. The table entries are colored
based on the specificity value ranging from blue (lowest
value) to red (highest value) (Figure 3).
Use cases and validation
The system has been tested on some known cases coming
from the literature. It has been able to identify miRNA–
disease and miRNA–process associations previously
reported, as shown in the next subsections.
The miR-17-92 cluster
The role of the miR-17-92 cluster in development and dis-
ease had been well established (16,17). The expression
of these miRNAs promotes cell proliferation, suppresses
apoptosis of cancer cells, and induces tumor angiogenesis.
In particular they are involved in ‘lymphoma’, ‘melanoma’
and other types of cancer (‘breast’, ‘colorectal’, ‘lung’,
‘ovarian’, ‘pancreas’, ‘prostate’ and ‘stomach’). The miR-
17-92 cluster also plays an essential role during normal
development of the heart, lungs, and immune system.
Performing an advanced search on miRo ` that searches
for the diseases related to subgroups of the miRNAs of
the cluster, one finds that four of them (miR-17, miR-19a,
miR-19b and miR-92a) are associated to those tumors
together with other pathologies. Moreover, an advanced
search for the processes involving the cluster returns,
among others, ‘angiogenesis’, ‘apoptosis’, ‘cell cycle’, ‘cell
growth’ and ‘proliferation’, ‘heart and lung development’.
Figure 2. An example of Advanced Query execution. (a) The advanced search form with the selected constraints: miRNAs
involved in heart failure, apoptosis and RNA binding, but not in Congenital heart disease will be returned. (b) A subset of
the corresponding results. For example, the miRNA let-7a satisfies the specified requirements. In particular it is predicted to bind
seven genes, which are involved in the heart failure disease. The details about the other constraints (apoptosis and RNA binding)
are shown in the GO Terms folder.
.............................................................................................................................................................................................................................................................................................
Page 4 of 7
Original article Database, Vol. 2009, Article ID bap008, doi:10.1093/database/bap008
.............................................................................................................................................................................................................................................................................................These processes are also linked to the diseases reported
in (16,17).
Other cases
The search through the miRo ` Advanced Search form for
the miRNAs miR-1, miR-206 and miR-133a, independently
known to be involved in muscle activity (18), shows
the involvement of such miRNAs in ‘muscle contraction’.
Moreover, the data mining analysis detects a high correla-
tion of miR-1 and miR-206, which are frequently associated
in terms of both biological processes and pathologies.
Similarly, miR-124 and miR-137, which have been inde-
pendently reported to be involved in ‘glioblastoma’ (19),
are associated together to several processes, among
which ‘gliogenesis’.
Validation of the specificity function
The specificity function, introduced in the previous section,
aims at scoring the miRNA annotations in order to highlight
the most significant ones.
Among the top ranking miRNA–disease and miRNA–
process associations, there are cases which have been
reported in literature, as shown in Tables 1 and 2. For
example, the top scoring miRNA–disease association links
miR-433 to ‘Parkinson’s disease’. This result is confirmed
by a study which has shown that the disruption of the
miR-433-binding site of the gene FGF20, confers risk for
Parkinson’s disease. Indeed, the increase in translation of
Table 1. Top ranking miRNA–disease associations reported in
literature
Rank miRNA Disease Reference
1 miR-23b Leukemia (22)
1 miR-433 Parkinson’s disease (20)
2 miR-107 Alzheimer’s disease (23)
2 miR-27b Leukemia (24)
2 miR-9 Alzheimer’s disease (25)
3 miR-20a Lung carcinoma (26)
3 miR-29a Alzheimer’s disease (25)
Table 2. Top ranking miRNA–process associations reported in
literature
Rank miRNA Process Reference
2 miR-212 Cell–cell junction assembly (27)
6 miR-224 Apoptosis (21)
7 miR-433 Fibroblast growth factor
receptor signaling
pathway, Cell growth
(20)
9 miR-221 Cell-cycle arrest (28)
9 miR-222 Cell-cycle arrest (28)
11 miR-219-5p Apoptosis (29)
Figure 3. An example of an miRNA subset containing two miRNAs (miR-124 and miR-137) both involved in 17 processes. The
entries contain the miRNA–process specificity scores. The entries are colored based on their value: the red entries indicate the
maximum value of the subset, while the blue ones indicate the minimum values. In this case, the most relevant associations in
the subset are between miR-137 and the four processes corresponding to the red entries. This may suggest a specific role of
miR-137 in such processes and is due to the number of targets of the miRNA involved in such processes and to their specificity to
the processes.
.............................................................................................................................................................................................................................................................................................
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sion, which is known to cause Parkinson’s diseases (20).
Similarly, the association between miR-224 and ‘apop-
tosis’ is among the top ranking miRNA–process associations.
This is supported by a study showing that miR-224, which
is up-regulated in Hepatocellular carcinoma patients,
increases apoptotic cell death by targeting the apoptosis
inhibitor-5 (API-5) (21).
Conclusions
miRo ` is an extensible web-based system which provides
users with miRNA functional annotations inferred through
their validated and predicted targets. The system is con-
ceived as an extensible and automatically updatable knowl-
edge base with powerful data mining facilities. The main
novelty of miRo ` is the introduction of a new layer of asso-
ciations between genes and processes/diseases based
on miRNAs annotations and a specificity function which
allows the selection of the most significant associations
among validated data.
Several new data sources will soon be integrated includ-
ing pathway data, target polymorphisms and target expres-
sion levels as well as cross-species conservation data. We
are also developing a new scoring function for miRNA’s
annotations based on the semantic associations between
terms, mined from the biomedical literature.
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